Cargando…
Retracted: Potential Use of Anti-Cancer Drugs for Treatment of Preeclampsia by Targeting the miRNA-IGF1R-PI3K-AKT Axis
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567319/ https://www.ncbi.nlm.nih.gov/pubmed/37829624 http://dx.doi.org/10.1155/2023/9764530 |
| _version_ | 1785119100243017728 |
|---|---|
| author | and Alternative Medicine, Evidence-Based Complementary |
| author_facet | and Alternative Medicine, Evidence-Based Complementary |
| author_sort | and Alternative Medicine, Evidence-Based Complementary |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10567319 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Hindawi |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105673192023-10-12 Retracted: Potential Use of Anti-Cancer Drugs for Treatment of Preeclampsia by Targeting the miRNA-IGF1R-PI3K-AKT Axis and Alternative Medicine, Evidence-Based Complementary Evid Based Complement Alternat Med Retraction Hindawi 2023-10-04 /pmc/articles/PMC10567319/ /pubmed/37829624 http://dx.doi.org/10.1155/2023/9764530 Text en Copyright © 2023 Evidence-Based Complementary and Alternative Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Retraction and Alternative Medicine, Evidence-Based Complementary Retracted: Potential Use of Anti-Cancer Drugs for Treatment of Preeclampsia by Targeting the miRNA-IGF1R-PI3K-AKT Axis |
| title | Retracted: Potential Use of Anti-Cancer Drugs for Treatment of Preeclampsia by Targeting the miRNA-IGF1R-PI3K-AKT Axis |
| title_full | Retracted: Potential Use of Anti-Cancer Drugs for Treatment of Preeclampsia by Targeting the miRNA-IGF1R-PI3K-AKT Axis |
| title_fullStr | Retracted: Potential Use of Anti-Cancer Drugs for Treatment of Preeclampsia by Targeting the miRNA-IGF1R-PI3K-AKT Axis |
| title_full_unstemmed | Retracted: Potential Use of Anti-Cancer Drugs for Treatment of Preeclampsia by Targeting the miRNA-IGF1R-PI3K-AKT Axis |
| title_short | Retracted: Potential Use of Anti-Cancer Drugs for Treatment of Preeclampsia by Targeting the miRNA-IGF1R-PI3K-AKT Axis |
| title_sort | retracted: potential use of anti-cancer drugs for treatment of preeclampsia by targeting the mirna-igf1r-pi3k-akt axis |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567319/ https://www.ncbi.nlm.nih.gov/pubmed/37829624 http://dx.doi.org/10.1155/2023/9764530 |
| work_keys_str_mv | AT andalternativemedicineevidencebasedcomplementary retractedpotentialuseofanticancerdrugsfortreatmentofpreeclampsiabytargetingthemirnaigf1rpi3kaktaxis |